Maynard Um
-
-
-
-
-
-
-
CVRX begins heart failure trial for expanded patient population
-
-
-
-
-
-
-
CVRx, Inc. (CVRX) Tops Q3 EPS by 1c ; Offers Guidance
-
-
-
-
-
-
-
Cantor Fitzgerald Reiterates Overweight Rating on CVRx Inc (CVRX)
-
-
-
-
-
-
-
CVRx Inc (CVRX) PT Lowered to $20 at Cantor Fitzgerald
-
-
-
-
-
-
-
CVRx Inc (CVRX) PT Raised to $17 at Canaccord Genuity
-
-
-
-
-
-
-
CVRx (CVRX) Announces Increased Inpatient Payment for Barostim Procedure
-
-
-
-
-
-
396,470 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

